Alerts will be sent to your verified email
Verify EmailSTARIMAGIN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Star Imaging and Path Lab is primarily engaged in operating pathology and diagnostic centers. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases.
Star Imaging & Path major competitors are Chandan Healthcare, Vijaya Diagnostic, Metropolis Health..
Market Cap of Star Imaging & Path is ₹167 Crs.
While the median market cap of its peers are ₹11,883 Crs.
Star Imaging & Path seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | May | ||||||||||||||||||
| Conference Call | May | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Claude
|
